Skip to main content
logo
Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
30.65
-2.53 (-7.63%)
At close: Nov 6, 2026, 4:00 PM EST
30.56
-0.09 (-0.29%)
After-hours: Nov 6, 2026, 7:58 PM EST

Oscar Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Premiums & Annuity Revenue
5,0424,7894,5812,7472,9242,8032,9962,3452,3682,1642,0941,3901,3921,4751,429978.21960.2999.13958.61532.77
Total Interest & Dividend Income
91.0284.7960.6149.6153.225446.1142.4250.3349.9942.9935.5442.3741.4836.0619.627.082.27-1.13-4.92
Gain (Loss) on Sale of Investments
---------------5.37-1.73--5.25
Other Revenue
6.36.15.728.978.86.54.334.814.95.235.635.725.545.0952.6819.4220.4518.493.15
Total Revenue
5,1394,8804,6472,8052,9862,8643,0462,3922,4232,2192,1421,4321,4401,5221,4701,006984.971,022975.97536.25
Revenue Growth (YoY)
72.11%70.40%52.55%17.25%23.21%29.04%42.20%67.11%68.30%45.86%45.77%42.33%46.20%48.90%50.59%87.58%119.54%92.73%157.56%557.73%
Policy Benefits
4,2333,7943,2302,6202,5862,5532,2602,0652,0041,7091,5551,2051,1631,1821,092884.9852.69808.64734.57482.49
Depreciation & Amortization
6.546.067.027.887.316.976.739.237.57.67.817.749.198.824.94-----
Selling, General & Administrative
721.89691.08706.23511.03521.59534.49482.76465.82460.38435.21394.16364.15325.85337.24398.52169.96121.11134.92129.9280.68
Other Operating Expenses
---------------182.82162.02157.79152.32124.43
Total Operating Expenses
4,9614,4923,9433,1393,1153,0942,7492,5402,4722,1521,9571,5771,4981,5281,4951,2281,1771,1281,044731.61
Operating Income
178.02388.64704.09-333.75-129.25-230.48297.12-147.73-48.3767.81185.56-145.48-58.24-6.53-25.37-222.43-192.37-106.49-68.53-195.36
Interest Expense
-4.73-4.71-5.38--6.86-5.85-5.99-6.03-5.82-5.99-5.9-6.22-6.13-6.12-6.14-6.14-6.13-6.14-4.22-0.4
Interest & Investment Income
---1.1----------------
Other Non Operating Income (Expenses)
2.09-0.920.07-20.03-3.182.79-2.920.071.88-0.87-1.181.05-0.41-1.61-6.111.343.340.79-3.05-1.2
EBT Excluding Unusual Items
175.38383.01698.77-352.68-139.29-233.54288.21-153.69-52.3160.95178.48-150.64-64.79-14.26-37.61-227.23-195.16-111.84-75.8-196.95
Other Unusual Items
----------------0.05----0.9
Pretax Income
175.38383.01698.77-352.68-139.29-233.54288.21-153.69-52.3160.95178.48-150.64-64.79-14.26-37.61-227.28-195.16-111.84-75.8-197.85
Income Tax Expense
8.0821.1819.75-0.25-1.81-5.0512.71-0.42.084.641-0.810.921.162.02-0.72-1.620.291.52-0.11
Earnings From Continuing Ops.
167.3361.83679.02-352.43-137.48-228.49275.51-153.29-54.3956.31177.48-149.84-65.7-15.43-39.63-226.56-193.55-112.13-77.32-197.74
Minority Interest in Earnings
-0.02-0.02-0.03-0.180.030.13-0.24-0.26-0.21-0.11-0.11-0.190.31-0.1-0.140.510.63-0.042.17-1.18
Net Income
167.28361.81679-352.61-137.45-228.36275.27-153.55-54.656.21177.37-150.03-65.4-15.53-39.77-226.05-192.91-112.16-75.15-198.92
Net Income to Common
167.28361.81679-352.61-137.45-228.36275.27-153.55-54.656.21177.37-150.03-65.4-15.53-39.77-226.05-192.91-112.16-75.15-198.92
Net Income Growth (YoY)
--146.66%---55.20%-------------
Shares Outstanding (Basic)
309302298283259256251248243239231227223219217215213211211210
Shares Outstanding (Diluted)
346333330283259256306248243304294227223219217215213211211210
Shares Change (YoY)
33.63%30.49%7.78%14.12%6.65%-15.93%4.13%9.30%8.97%38.54%35.44%5.52%4.83%3.83%3.02%2.58%2.24%1.85%136.93%593.93%
EPS (Basic)
0.541.202.28-1.24-0.53-0.891.10-0.62-0.220.240.77-0.66-0.29-0.07-0.18-1.05-0.91-0.53-0.36-0.95
EPS (Diluted)
0.491.102.07-1.25-0.53-0.890.92-0.68-0.220.200.62-0.66-0.29-0.07-0.18-1.05-0.91-0.53-0.36-0.95
EPS Growth (YoY)
--125.61%---47.21%-------------

Additional Metrics

Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period Ending
Sep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Free Cash Flow
-1,2122,0812,610662.84-973.67499.79869.52340-507.71489.59628.41290.77-1,156159.91407.34144.26-557.98208.45556.627.27
Free Cash Flow Per Share
-3.506.247.922.34-3.751.962.841.37-2.091.612.141.28-5.180.731.880.67-2.620.992.640.13
Operating Margin
3.46%7.96%15.15%-11.90%-4.33%-8.05%9.75%-6.17%-2.00%3.06%8.66%-10.16%-4.04%-0.43%-1.73%-22.11%-19.53%-10.42%-7.02%-36.43%
Profit Margin
3.26%7.41%14.61%-12.57%-4.60%-7.97%9.04%-6.42%-2.25%2.53%8.28%-10.48%-4.54%-1.02%-2.71%-22.47%-19.59%-10.98%-7.70%-37.09%
Free Cash Flow Margin
-23.58%42.63%56.17%23.63%-32.61%17.45%28.54%14.21%-20.95%22.06%29.33%20.31%-80.26%10.51%27.72%14.34%-56.65%20.40%57.03%5.09%
EBITDA
184.56394.67711.1-325.87-121.94-223.51303.85-138.5-40.8775.41193.37-137.74-49.052.29-20.43-218.7-188.31-102.8-64.73-191.39
EBITDA Margin
3.59%8.09%15.30%-11.62%-4.08%-7.80%9.98%-5.79%-1.69%3.40%9.03%-9.62%-3.41%0.15%-1.39%-21.74%-19.12%-10.06%-6.63%-35.69%
D&A For EBITDA
6.546.037.027.887.316.976.739.237.57.67.817.749.198.824.943.744.063.693.83.97
EBIT
178.02388.64704.09-333.75-129.25-230.48297.12-147.73-48.3767.81185.56-145.48-58.24-6.53-25.37-222.43-192.37-106.49-68.53-195.36
EBIT Margin
3.46%7.96%15.15%-11.90%-4.33%-8.05%9.75%-6.17%-2.00%3.06%8.66%-10.16%-4.04%-0.43%-1.73%-22.11%-19.53%-10.42%-7.02%-36.43%
Effective Tax Rate
4.61%5.53%2.83%---4.41%--7.61%0.56%---------
Revenue as Reported
5,1394,8804,6472,8052,9862,8643,0462,3922,423-2,1421,4321,440-------
SEC Filings: 10-K · 10-Q